Sunshine Biopharma (SBFMW) Stock Price & News

All values in USD	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	9.42M	8.58M	8.09M	9.26M
Cost of goods sold	6.34M	5.55M	5.91M	6.84M
Cost of revenue	6.34M	5.55M	5.91M	6.84M
Research and development expenses	119.30K	73.50K	31.72K	13.22K
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	3.27M	4.39M	3.34M	3.81M
Operating expense	3.61M	4.69M	3.58M	4.04M
Total operating expenses	9.95M	10.24M	9.48M	10.88M
Operating income	-531.96K	-1.66M	-1.40M	-1.61M
Other non operating income	-	-	103.32K	-
EBT including unusual items	-1.02M	-1.73M	-1.24M	-1.56M
EBT excluding unusual items	-456.36K	-1.60M	-1.24M	-1.56M
Income tax expense	-137.44K	408.37K	-	-
Effective tax rate	13.46%	-23.57%	-	-
Other operating expenses	119.91K	126.54K	129.66K	138.49K
Net income	-883.82K	-2.14M	-1.24M	-1.56M
Net profit margin	-9.39%	-24.96%	-15.38%	-16.88%
Earnings per share	-	-	-	-
Interest and investment income	75.35K	57.47K	48.43K	48.82K
Interest expense	-	-	-	-
Net interest expenses	75.35K	57.47K	48.43K	48.82K
Depreciation and amortization charges	95.82K	98.92K	76.86K	77.97K
EBITDA	-435.80K	-1.56M	-1.32M	-1.53M
Gain or loss from assets sale	-	-	-	-

Finance